Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1237, 2000-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Smilde T.J.
Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. :
Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Ezetimibe/simvastatin lowers LDL-cholesterol to target levels
Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. :
Nicotinic acid/lovastatin better value than simvastatin for lipid lowering
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Atorvastatin and simvastatin, unlike fenofibrate, have a neutral effect on serum homocysteine levels
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :